Nifty
Sensex
:
:
15803.90
52742.22
25.45 (0.16%)
89.15 (0.17%)

Pharmaceuticals & Drugs

Rating :
43/99

BSE: 524824 | NSE: BALPHARMA

94.80
29-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  93.15
  •  96.45
  •  93.15
  •  94.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11537
  •  10.96
  •  137.70
  •  39.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 140.59
  • 246.65
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 255.91
  • N/A
  • 1.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.84%
  • 0.67%
  • 38.37%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 16.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.08
  • -2.89
  • -6.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.18
  • -16.33
  • -21.04

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.72
  • 29.37
  • 13.88

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.63
  • 1.68
  • 1.42

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.19
  • 13.00
  • 13.08

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
0.00
33.77
-100.00%
63.03
43.17
46.00%
64.56
44.99
43.50%
52.13
49.16
6.04%
Expenses
0.00
33.14
-100.00%
57.10
42.47
34.45%
57.46
43.15
33.16%
47.05
47.57
-1.09%
EBITDA
0.00
0.63
-100.00%
5.93
0.70
747.14%
7.10
1.83
287.98%
5.08
1.59
219.50%
EBIDTM
0.00%
1.87%
9.41%
1.63%
11.00%
4.07%
9.75%
3.24%
Other Income
0.00
1.17
-100.00%
0.19
0.41
-53.66%
0.06
0.03
100.00%
0.16
0.23
-30.43%
Interest
0.00
3.02
-100.00%
2.89
2.81
2.85%
3.19
3.33
-4.20%
2.79
3.29
-15.20%
Depreciation
0.00
3.59
-100.00%
2.03
1.42
42.96%
2.17
1.35
60.74%
1.88
1.32
42.42%
PBT
0.00
-4.80
-
1.20
-3.11
-
1.81
-2.83
-
0.57
-2.79
-
Tax
0.00
-0.07
-
0.80
0.60
33.33%
1.31
-0.84
-
0.29
-0.33
-
PAT
0.00
-4.74
-
0.40
-3.71
-
0.50
-1.99
-
0.28
-2.46
-
PATM
0.00%
-14.02%
0.64%
-8.58%
0.77%
-4.42%
0.54%
-5.01%
EPS
0.00
-3.34
-
0.22
-2.52
-
0.30
-1.29
-
0.30
-1.62
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Net Sales
213.49
171.09
225.01
209.29
228.91
198.32
187.16
178.87
114.29
106.23
103.60
Net Sales Growth
10.97%
-23.96%
7.51%
-8.57%
15.42%
5.96%
4.63%
56.51%
7.59%
2.54%
 
Cost Of Goods Sold
122.59
75.25
104.04
88.57
103.94
94.06
87.49
83.74
54.71
55.24
48.46
Gross Profit
90.90
95.84
120.96
120.71
124.97
104.25
99.67
95.14
59.58
50.99
55.14
GP Margin
42.58%
56.02%
53.76%
57.68%
54.59%
52.57%
53.25%
53.19%
52.13%
48.00%
53.22%
Total Expenditure
194.75
166.05
207.33
191.95
214.10
183.46
170.05
161.00
104.36
100.95
93.07
Power & Fuel Cost
-
4.76
6.38
6.07
6.17
4.66
4.54
4.39
2.90
2.13
2.13
% Of Sales
-
2.78%
2.84%
2.90%
2.70%
2.35%
2.43%
2.45%
2.54%
2.01%
2.06%
Employee Cost
-
50.43
50.28
52.16
45.37
37.30
32.24
28.12
20.58
19.73
20.37
% Of Sales
-
29.48%
22.35%
24.92%
19.82%
18.81%
17.23%
15.72%
18.01%
18.57%
19.66%
Manufacturing Exp.
-
15.80
20.28
18.03
21.44
19.80
20.78
18.23
11.24
8.90
7.84
% Of Sales
-
9.23%
9.01%
8.61%
9.37%
9.98%
11.10%
10.19%
9.83%
8.38%
7.57%
General & Admin Exp.
-
7.48
9.27
11.21
16.82
13.98
12.43
11.54
5.41
4.71
4.42
% Of Sales
-
4.37%
4.12%
5.36%
7.35%
7.05%
6.64%
6.45%
4.73%
4.43%
4.27%
Selling & Distn. Exp.
-
11.11
15.74
15.63
19.50
13.18
11.91
13.49
8.73
9.62
8.90
% Of Sales
-
6.49%
7.00%
7.47%
8.52%
6.65%
6.36%
7.54%
7.64%
9.06%
8.59%
Miscellaneous Exp.
-
1.23
1.33
0.27
0.86
0.47
0.65
1.48
0.78
0.62
8.90
% Of Sales
-
0.72%
0.59%
0.13%
0.38%
0.24%
0.35%
0.83%
0.68%
0.58%
0.92%
EBITDA
18.74
5.04
17.68
17.34
14.81
14.86
17.11
17.87
9.93
5.28
10.53
EBITDA Margin
8.78%
2.95%
7.86%
8.29%
6.47%
7.49%
9.14%
9.99%
8.69%
4.97%
10.16%
Other Income
1.58
1.84
1.01
1.73
3.04
1.28
1.17
0.65
0.79
2.94
0.12
Interest
11.89
12.73
12.74
9.41
8.49
6.48
6.52
7.16
6.79
6.26
4.71
Depreciation
9.67
7.68
6.16
6.77
6.49
7.01
7.02
4.74
2.90
2.86
1.89
PBT
-1.22
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
4.06
Tax
2.33
-0.64
-2.36
2.51
3.27
2.39
1.19
1.55
0.63
0.52
1.06
Tax Rate
-190.98%
4.73%
1180.00%
87.15%
113.94%
90.19%
25.11%
23.38%
60.58%
-57.14%
26.11%
PAT
-3.56
-12.22
3.79
2.79
1.75
1.41
3.62
5.07
0.41
-1.43
2.99
PAT before Minority Interest
-3.58
-12.89
2.15
0.38
-0.40
0.26
3.55
5.07
0.41
-1.43
2.99
Minority Interest
-0.02
0.67
1.64
2.41
2.15
1.15
0.07
0.00
0.00
0.00
0.00
PAT Margin
-1.67%
-7.14%
1.68%
1.33%
0.76%
0.71%
1.93%
2.83%
0.36%
-1.35%
2.89%
PAT Growth
0.00%
-
35.84%
59.43%
24.11%
-61.05%
-28.60%
1,136.59%
-
-
 
EPS
-2.41
-8.26
2.56
1.89
1.18
0.95
2.45
3.43
0.28
-0.97
2.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Shareholder's Funds
52.43
66.64
64.99
62.45
54.90
55.20
50.05
36.18
35.76
37.23
Share Capital
14.17
14.17
14.17
14.17
12.87
12.87
11.11
10.48
10.48
10.48
Total Reserves
38.25
52.47
50.82
48.27
40.01
40.31
37.20
25.50
25.09
26.52
Non-Current Liabilities
33.56
37.85
45.57
30.02
45.12
16.34
17.92
64.54
60.66
52.96
Secured Loans
23.15
28.76
33.25
12.76
15.24
6.11
6.58
53.76
54.41
46.34
Unsecured Loans
0.00
0.00
1.43
5.04
19.71
0.53
1.39
3.97
0.01
0.83
Long Term Provisions
3.62
2.71
2.05
3.42
2.28
1.65
1.06
0.00
0.00
0.00
Current Liabilities
159.49
163.24
154.40
143.24
111.19
92.36
86.77
34.59
27.78
31.47
Trade Payables
38.67
47.34
49.96
54.43
46.85
38.53
33.53
27.02
22.07
22.62
Other Current Liabilities
30.69
27.86
33.77
16.45
12.01
11.86
8.66
6.03
4.73
6.49
Short Term Borrowings
89.63
87.08
68.31
71.07
50.09
40.14
42.75
0.00
0.00
0.00
Short Term Provisions
0.50
0.96
2.37
1.29
2.24
1.83
1.83
1.53
0.99
2.36
Total Liabilities
238.39
261.31
260.17
233.33
211.03
163.87
154.74
135.31
124.20
121.66
Net Block
70.71
70.39
71.48
59.98
56.23
52.20
55.18
54.26
54.98
54.93
Gross Block
97.70
89.76
84.71
66.44
106.10
95.14
90.11
76.86
74.11
67.45
Accumulated Depreciation
27.00
19.37
13.23
6.46
49.87
42.95
34.93
22.60
19.13
12.53
Non Current Assets
77.26
78.26
75.41
68.78
68.03
58.74
59.63
54.40
55.00
55.34
Capital Work in Progress
3.32
3.63
0.21
1.70
3.93
0.77
0.25
0.13
0.00
0.40
Non Current Investment
0.00
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
1.67
1.69
3.15
6.61
7.54
5.42
3.95
0.00
0.00
0.00
Other Non Current Assets
1.56
2.54
0.55
0.46
0.32
0.34
0.24
0.00
0.00
0.00
Current Assets
161.14
183.05
184.77
164.55
143.00
105.12
95.12
80.90
69.20
61.38
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
67.71
69.75
66.49
54.73
41.75
35.82
31.71
32.21
28.62
23.89
Sundry Debtors
49.60
64.70
64.05
61.80
56.94
44.98
45.49
37.02
31.92
29.29
Cash & Bank
3.13
4.32
4.15
4.71
4.63
5.49
3.02
2.23
1.61
1.49
Other Current Assets
40.69
0.70
0.24
0.86
39.66
18.83
14.89
9.44
7.05
6.73
Short Term Loans & Adv.
40.36
43.58
49.83
42.45
38.45
17.48
13.96
5.56
4.59
3.62
Net Current Assets
1.64
19.81
30.36
21.31
31.81
12.77
8.35
46.31
41.42
29.91
Total Assets
238.40
261.31
260.18
233.33
211.03
163.86
154.75
135.30
124.20
121.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
23.10
7.76
0.58
6.31
-19.35
14.53
13.31
4.61
-5.22
12.89
PBT
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
4.06
Adjustment
18.88
17.41
15.14
14.79
11.46
11.69
10.43
9.49
7.12
6.56
Changes in Working Capital
17.94
-7.07
-16.18
-9.95
-32.66
-0.59
-2.59
-6.10
-10.70
3.29
Cash after chg. in Working capital
23.28
10.13
1.84
7.72
-18.55
15.84
14.47
4.43
-4.48
13.90
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.18
-2.38
-1.27
-1.40
-0.80
-1.31
-1.16
0.18
-0.74
-1.01
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-4.71
-8.04
-3.56
-7.96
-13.88
-5.30
-7.30
-1.59
4.61
-11.34
Net Fixed Assets
-6.22
-4.61
-3.80
41.86
-12.93
-5.24
-15.62
-2.86
-6.26
-11.18
Net Investments
0.02
0.00
-7.42
1.16
-0.09
-1.07
0.04
0.00
0.03
0.00
Others
1.49
-3.43
7.66
-50.98
-0.86
1.01
8.28
1.27
10.84
-0.16
Cash from Financing Activity
-19.97
0.01
3.53
-5.94
32.37
-6.80
-7.52
-2.40
0.74
-2.96
Net Cash Inflow / Outflow
-1.58
-0.27
0.55
-7.58
-0.86
2.43
-1.51
0.62
0.13
-1.41
Opening Cash & Equivalents
2.44
2.71
2.16
-17.72
5.49
3.02
4.53
1.61
1.49
2.90
Closing Cash & Equivalent
0.86
2.44
2.71
-25.30
4.63
5.45
3.02
2.23
1.61
1.49

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
36.99
47.02
45.86
44.06
41.09
41.32
43.48
34.33
33.94
30.59
ROA
-5.16%
0.83%
0.15%
-0.18%
0.14%
2.23%
3.50%
0.31%
-1.16%
2.60%
ROE
-21.65%
3.27%
0.59%
-0.69%
0.49%
7.00%
12.03%
1.14%
-4.22%
9.62%
ROCE
-0.44%
6.88%
7.45%
7.59%
7.35%
10.88%
14.05%
8.51%
6.31%
11.32%
Fixed Asset Turnover
1.83
2.58
2.80
2.72
2.01
2.06
2.18
1.60
1.58
2.12
Receivable days
121.92
104.42
108.60
92.23
91.87
86.58
82.73
104.23
99.58
86.63
Inventory Days
146.63
110.50
104.61
74.94
69.91
64.63
64.10
91.99
85.43
81.22
Payable days
90.28
86.70
99.47
88.16
89.31
79.05
72.93
89.00
77.88
79.60
Cash Conversion Cycle
178.26
128.22
113.74
79.02
72.47
72.17
73.90
107.22
107.13
88.25
Total Debt/Equity
2.26
1.85
1.69
1.49
1.68
0.93
1.08
1.60
1.53
1.47
Interest Cover
-0.06
0.98
1.31
1.34
1.41
1.73
1.93
1.15
0.86
1.86

News Update:


  • Bal Pharma launches Favipiravir formulation into Indian market
    25th May 2021, 10:17 AM

    Favipiravir inhibits and terminates viral protein synthesis and induces lethal metagenesis of influenza virus

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.